AMIODARONE AND SOTALOL IN ATRIAL FIBRILLATION: TREATMENT PERSISTENCE AND OCCURRENCE OF ADVERSE EVENTS IN THE REAL-WORLD SETTING

被引：0
|
作者：
Kim, Michael H.
Smith, Paula J.
Jhaveri, Mehul
Lin, Jay
Klingman, David
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Sanofi Aventis US, Bridgewater, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 14期
关键词：
D O I：
10.1016/S0735-1097(11)61247-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1247 / E1247
页数：1
相关论文
共 50 条
  • [1] A REAL-WORLD DISPROPORTIONALITY ANALYSIS OF ATRIAL FIBRILLATION ADVERSE EVENTS ASSOCIATED WITH BISPHOSPHONATES
    Thakre, Anuj
    Babbili, Akhilesh
    Thotamgari, Sahith Reddy
    Nanavaty, Dhairya
    Sheth, Aakash
    Sanghvi, Ankushi
    Brar, Vijaywant
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 86 - 86
  • [2] One-Year Treatment Persistence and Potential Adverse Events Among Patients With Atrial Fibrillation Treated With Amiodarone or Sotalol: A Retrospective Claims Database Analysis
    Kim, Michael H.
    Smith, Paula J.
    Jhaveri, Mehul
    Lin, Jay
    Klingman, David
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1668 - 1681
  • [3] Risk Prediction for Adverse Events during Initiation of Sotalol and Dofetilide for the Treatment of Atrial Fibrillation
    Agusala, Kartik
    Oesterle, Adam
    Kulkarni, Chiraag
    Caprio, Timothy
    Subacius, Haris
    Passman, Rod
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (04): : 490 - 498
  • [4] Risk Prediction for Adverse Events During Initiation of Sotalol and Dofetilide for the Treatment of Atrial Fibrillation
    Aousala, Kartik
    Oesterle, Adam C.
    Caprio, Tim W.
    Subacius, Haris
    Passman, Rod S.
    CIRCULATION, 2013, 128 (22)
  • [5] New Direct Oral Anticoagulants for Treatment of Patients with Atrial Fibrillation in Real-World Setting
    Kobalava, Zhanna D.
    Villevalde, Svetlana V.
    Shavarov, Andrey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2018, 14 (02) : 298 - 305
  • [6] PERSISTENCE WITH AMIODARONE OR SOTALOL AND ITS IMPACT ON ATRIAL FIBRILLATION-RELATED HOSPITALIZATIONS AND CARDIOVERSIONS
    Ishak, K. J.
    Proskorovsky, I
    Guo, S.
    Lin, J.
    Caro, J. J.
    VALUE IN HEALTH, 2008, 11 (06) : A408 - A408
  • [7] Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
    Manzoor, Beenish S.
    Lee, Todd A.
    Sharp, Lisa K.
    Walton, Surrey M.
    Galanter, William L.
    Nutescu, Edith A.
    PHARMACOTHERAPY, 2017, 37 (10): : 1221 - 1230
  • [8] Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation
    Pignatelli, P.
    Pastori, D.
    Lip, G.
    Violi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 392 - 392
  • [9] MIXED TREATMENT COMPARISON OF DRONEDARONE, AMIODARONE AND SOTALOL FOR THE MANAGEMENT OF ATRIAL FIBRILLATION IN AUSTRALIA
    Badcock, C. A.
    Lee, J.
    Gonzalo, F.
    VALUE IN HEALTH, 2011, 14 (07) : A366 - A366
  • [10] Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation: A Real-World Setting
    Fontaine, Gabriel V.
    Mathews, Katy D.
    Woller, Scott C.
    Stevens, Scott M.
    Lloyd, James F.
    Evans, R. Scott
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 665 - 672
12345